 | • レポートコード：QYR9ST09344 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、RNAワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチンに、用途別には、感染症、がん、その他にセグメント区分し、RNAワクチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・RNAワクチンの世界市場概要 ・RNAワクチンの製造コスト構成分析 ・RNAワクチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・RNAワクチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・RNAワクチンのセグメント分析（種類別） （個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン） ・RNAワクチンのセグメント分析（用途別） （感染症、がん、その他） ・RNAワクチンの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology） ・RNAワクチンの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of RNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
The global RNA Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on RNA Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall RNA Vaccines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of RNA Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their RNA Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Segment by Application
Infectious Disease
Cancer
Other
Table of Contents
Executive Summary
1 Industry Overview of RNA Vaccines
1.1 Definition of RNA Vaccines
1.2 RNA Vaccines Segment by Type
1.2.1 Global RNA Vaccines Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 RNA Vaccines Segment by Applications
1.3.1 Global RNA Vaccines Consumption Comparison by Applications (2014-2025)
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Global RNA Vaccines Overall Market
1.4.1 Global RNA Vaccines Revenue (2014-2025)
1.4.2 Global RNA Vaccines Production (2014-2025)
1.4.3 North America RNA Vaccines Status and Prospect (2014-2025)
1.4.4 Europe RNA Vaccines Status and Prospect (2014-2025)
1.4.5 China RNA Vaccines Status and Prospect (2014-2025)
1.4.6 Japan RNA Vaccines Status and Prospect (2014-2025)
1.4.7 Southeast Asia RNA Vaccines Status and Prospect (2014-2025)
1.4.8 India RNA Vaccines Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of RNA Vaccines
2.3 Manufacturing Process Analysis of RNA Vaccines
2.4 Industry Chain Structure of RNA Vaccines
3 Development and Manufacturing Plants Analysis of RNA Vaccines
3.1 Capacity and Commercial Production Date
3.2 Global RNA Vaccines Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of RNA Vaccines
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 RNA Vaccines Production and Capacity Analysis
4.2 RNA Vaccines Revenue Analysis
4.3 RNA Vaccines Price Analysis
4.4 Market Concentration Degree
5 RNA Vaccines Regional Market Analysis
5.1 RNA Vaccines Production by Regions
5.1.1 Global RNA Vaccines Production by Regions
5.1.2 Global RNA Vaccines Revenue by Regions
5.2 RNA Vaccines Consumption by Regions
5.3 North America RNA Vaccines Market Analysis
5.3.1 North America RNA Vaccines Production
5.3.2 North America RNA Vaccines Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America RNA Vaccines Import and Export
5.4 Europe RNA Vaccines Market Analysis
5.4.1 Europe RNA Vaccines Production
5.4.2 Europe RNA Vaccines Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe RNA Vaccines Import and Export
5.5 China RNA Vaccines Market Analysis
5.5.1 China RNA Vaccines Production
5.5.2 China RNA Vaccines Revenue
5.5.3 Key Manufacturers in China
5.5.4 China RNA Vaccines Import and Export
5.6 Japan RNA Vaccines Market Analysis
5.6.1 Japan RNA Vaccines Production
5.6.2 Japan RNA Vaccines Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan RNA Vaccines Import and Export
5.7 Southeast Asia RNA Vaccines Market Analysis
5.7.1 Southeast Asia RNA Vaccines Production
5.7.2 Southeast Asia RNA Vaccines Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia RNA Vaccines Import and Export
5.8 India RNA Vaccines Market Analysis
5.8.1 India RNA Vaccines Production
5.8.2 India RNA Vaccines Revenue
5.8.3 Key Manufacturers in India
5.8.4 India RNA Vaccines Import and Export
6 RNA Vaccines Segment Market Analysis (by Type)
6.1 Global RNA Vaccines Production by Type
6.2 Global RNA Vaccines Revenue by Type
6.3 RNA Vaccines Price by Type
7 RNA Vaccines Segment Market Analysis (by Application)
7.1 Global RNA Vaccines Consumption by Application
7.2 Global RNA Vaccines Consumption Market Share by Application (2014-2019)
8 RNA Vaccines Major Manufacturers Analysis
8.1 Moderna Therapeutics
8.1.1 Moderna Therapeutics RNA Vaccines Production Sites and Area Served
8.1.2 Moderna Therapeutics Product Introduction, Application and Specification
8.1.3 Moderna Therapeutics RNA Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 CureVac
8.2.1 CureVac RNA Vaccines Production Sites and Area Served
8.2.2 CureVac Product Introduction, Application and Specification
8.2.3 CureVac RNA Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Translate Bio
8.3.1 Translate Bio RNA Vaccines Production Sites and Area Served
8.3.2 Translate Bio Product Introduction, Application and Specification
8.3.3 Translate Bio RNA Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 BioNTech
8.4.1 BioNTech RNA Vaccines Production Sites and Area Served
8.4.2 BioNTech Product Introduction, Application and Specification
8.4.3 BioNTech RNA Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Sangamo Therapeutics
8.5.1 Sangamo Therapeutics RNA Vaccines Production Sites and Area Served
8.5.2 Sangamo Therapeutics Product Introduction, Application and Specification
8.5.3 Sangamo Therapeutics RNA Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Argos Therapeutics
8.6.1 Argos Therapeutics RNA Vaccines Production Sites and Area Served
8.6.2 Argos Therapeutics Product Introduction, Application and Specification
8.6.3 Argos Therapeutics RNA Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 In-Cell-Art
8.7.1 In-Cell-Art RNA Vaccines Production Sites and Area Served
8.7.2 In-Cell-Art Product Introduction, Application and Specification
8.7.3 In-Cell-Art RNA Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 eTheRNA
8.8.1 eTheRNA RNA Vaccines Production Sites and Area Served
8.8.2 eTheRNA Product Introduction, Application and Specification
8.8.3 eTheRNA RNA Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Ethris
8.9.1 Ethris RNA Vaccines Production Sites and Area Served
8.9.2 Ethris Product Introduction, Application and Specification
8.9.3 Ethris RNA Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Tiba Biotechnology
8.10.1 Tiba Biotechnology RNA Vaccines Production Sites and Area Served
8.10.2 Tiba Biotechnology Product Introduction, Application and Specification
8.10.3 Tiba Biotechnology RNA Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of RNA Vaccines Market
9.1 Global RNA Vaccines Market Trend Analysis
9.1.1 Global RNA Vaccines Market Size (Volume and Value) Forecast 2019-2025
9.2 RNA Vaccines Regional Market Trend
9.2.1 North America RNA Vaccines Forecast 2019-2025
9.2.2 Europe RNA Vaccines Forecast 2019-2025
9.2.3 China RNA Vaccines Forecast 2019-2025
9.2.4 Japan RNA Vaccines Forecast 2019-2025
9.2.5 Southeast Asia RNA Vaccines Forecast 2019-2025
9.2.6 India RNA Vaccines Forecast 2019-2025
9.3 RNA Vaccines Market Trend (Product Type)
9.4 RNA Vaccines Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 RNA Vaccines Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of RNA Vaccines
Table Global RNA Vaccines Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global RNA Vaccines Production Market Share by Types in 2018
Figure Individualized Cancer Treatment MRNA Vaccine Product Picture
Figure Infectious Disease Treatment MRNA Vaccine Product Picture
Figure Infection Prevention MRNA Vaccine Product Picture
Table Global RNA Vaccines Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global RNA Vaccines Consumption Market Share by Applications in 2018
Figure Infectious Disease
Figure Cancer
Figure Other
Figure Global RNA Vaccines Revenue (Million USD) (2014-2025)
Figure Global RNA Vaccines Production (K Doses) (2014-2025)
Figure North America RNA Vaccines Market Size (Million USD) (2014-2025)
Figure Europe RNA Vaccines Market Size (Million USD) (2014-2025)
Figure China RNA Vaccines Market Size (Million USD) (2014-2025)
Figure Japan RNA Vaccines Market Size (Million USD) (2014-2025)
Figure Southeast Asia RNA Vaccines Market Size (Million USD) (2014-2025)
Figure India RNA Vaccines Market Size (Million USD) (2014-2025)
Table RNA Vaccines Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of RNA Vaccines in 2018
Figure Manufacturing Process Analysis of RNA Vaccines
Figure Industry Chain Structure of RNA Vaccines
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global RNA Vaccines Manufacturing Plants Distribution
Table RNA Vaccines Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table RNA Vaccines Capacity (K Doses) of Major Manufacturers (2014-2019)
Table RNA Vaccines Production (K Doses) of Major Manufacturers (2014-2019)
Table RNA Vaccines Production Market Share of Major Manufacturers (2014-2019)
Figure RNA Vaccines Production Share by Manufacturers in 2018
Table RNA Vaccines Revenue (Million US$) of Major Manufacturers (2014-2019)
Table RNA Vaccines Revenue Market Share of Major Manufacturers (2014-2019)
Figure RNA Vaccines Revenue Share by Manufacturers in 2018
Table RNA Vaccines Average Price (USD/Dose) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global RNA Vaccines Production by Regions 2014-2019 (K Doses)
Table Global RNA Vaccines Production Market Share by Regions 2014-2019
Figure Global RNA Vaccines Production Market Share by Regions in 2018
Table Global RNA Vaccines Revenue by Regions 2014-2019 (Million USD)
Table Global RNA Vaccines Revenue Market Share by Regions 2014-2019
Figure Global RNA Vaccines Revenue Market Share by Regions in 2018
Table Global RNA Vaccines Consumption by Regions 2014-2019 (K Doses)
Table Global RNA Vaccines Consumption Market Share by Regions 2014-2019
Figure North America RNA Vaccines Production Growth Rate 2014-2019 (K Doses)
Figure North America RNA Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table North America RNA Vaccines Production, Consumption Import and Export (K Doses)
Figure Europe RNA Vaccines Production Growth Rate 2014-2019 (K Doses)
Figure Europe RNA Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table Europe RNA Vaccines Production, Consumption Import and Export (K Doses)
Figure China RNA Vaccines Production Growth Rate 2014-2019 (K Doses)
Figure China RNA Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table China RNA Vaccines Production, Consumption Import and Export (K Doses)
Figure Japan RNA Vaccines Production Growth Rate 2014-2019 (K Doses)
Figure Japan RNA Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table Japan RNA Vaccines Production, Consumption Import and Export (K Doses)
Figure Southeast Asia RNA Vaccines Production Growth Rate 2014-2019 (K Doses)
Figure Southeast Asia RNA Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia RNA Vaccines Production, Consumption Import and Export (K Doses)
Figure India RNA Vaccines Production Growth Rate 2014-2019 (K Doses)
Figure India RNA Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table India RNA Vaccines Production, Consumption Import and Export (K Doses)
Figure Global Consumption RNA Vaccines Market Share by Application (2014-2019)
Figure Global Value (Consumption) RNA Vaccines Market Share by Application (2014-2019)
Table Moderna Therapeutics RNA Vaccines Production Sites and Area Served
Table Moderna Therapeutics RNA Vaccines Product Introduction, Application and Specification
Table Moderna Therapeutics RNA Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Moderna Therapeutics RNA Vaccines Production Growth Rate (2014-2019)
Table Moderna Therapeutics RNA Vaccines Production Market Share (2014-2019)
Figure Moderna Therapeutics RNA Vaccines Revenue Market Share (2014-2019)
Table Moderna Therapeutics RNA Vaccines Main Business and Markets Served
Table CureVac RNA Vaccines Production Sites and Area Served
Table CureVac RNA Vaccines Product Introduction, Application and Specification
Table CureVac RNA Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table CureVac RNA Vaccines Production Growth Rate (2014-2019)
Table CureVac RNA Vaccines Production Market Share (2014-2019)
Figure CureVac RNA Vaccines Revenue Market Share (2014-2019)
Table CureVac RNA Vaccines Main Business and Markets Served
Table Translate Bio RNA Vaccines Production Sites and Area Served
Table Translate Bio RNA Vaccines Product Introduction, Application and Specification
Table Translate Bio RNA Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Translate Bio RNA Vaccines Production Growth Rate (2014-2019)
Table Translate Bio RNA Vaccines Production Market Share (2014-2019)
Figure Translate Bio RNA Vaccines Revenue Market Share (2014-2019)
Table Translate Bio RNA Vaccines Main Business and Markets Served
Table BioNTech RNA Vaccines Production Sites and Area Served
Table BioNTech RNA Vaccines Product Introduction, Application and Specification
Table BioNTech RNA Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table BioNTech RNA Vaccines Production Growth Rate (2014-2019)
Table BioNTech RNA Vaccines Production Market Share (2014-2019)
Figure BioNTech RNA Vaccines Revenue Market Share (2014-2019)
Table BioNTech RNA Vaccines Main Business and Markets Served
Table Sangamo Therapeutics RNA Vaccines Production Sites and Area Served
Table Sangamo Therapeutics RNA Vaccines Product Introduction, Application and Specification
Table Sangamo Therapeutics RNA Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Sangamo Therapeutics RNA Vaccines Production Growth Rate (2014-2019)
Table Sangamo Therapeutics RNA Vaccines Production Market Share (2014-2019)
Figure Sangamo Therapeutics RNA Vaccines Revenue Market Share (2014-2019)
Table Sangamo Therapeutics RNA Vaccines Main Business and Markets Served
Table Argos Therapeutics RNA Vaccines Production Sites and Area Served
Table Argos Therapeutics RNA Vaccines Product Introduction, Application and Specification
Table Argos Therapeutics RNA Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Argos Therapeutics RNA Vaccines Production Growth Rate (2014-2019)
Table Argos Therapeutics RNA Vaccines Production Market Share (2014-2019)
Figure Argos Therapeutics RNA Vaccines Revenue Market Share (2014-2019)
Table Argos Therapeutics RNA Vaccines Main Business and Markets Served
Table In-Cell-Art RNA Vaccines Production Sites and Area Served
Table In-Cell-Art RNA Vaccines Product Introduction, Application and Specification
Table In-Cell-Art RNA Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table In-Cell-Art RNA Vaccines Production Growth Rate (2014-2019)
Table In-Cell-Art RNA Vaccines Production Market Share (2014-2019)
Figure In-Cell-Art RNA Vaccines Revenue Market Share (2014-2019)
Table In-Cell-Art RNA Vaccines Main Business and Markets Served
Table eTheRNA RNA Vaccines Production Sites and Area Served
Table eTheRNA RNA Vaccines Product Introduction, Application and Specification
Table eTheRNA RNA Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table eTheRNA RNA Vaccines Production Growth Rate (2014-2019)
Table eTheRNA RNA Vaccines Production Market Share (2014-2019)
Figure eTheRNA RNA Vaccines Revenue Market Share (2014-2019)
Table eTheRNA RNA Vaccines Main Business and Markets Served
Table Ethris RNA Vaccines Production Sites and Area Served
Table Ethris RNA Vaccines Product Introduction, Application and Specification
Table Ethris RNA Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Ethris RNA Vaccines Production Growth Rate (2014-2019)
Table Ethris RNA Vaccines Production Market Share (2014-2019)
Figure Ethris RNA Vaccines Revenue Market Share (2014-2019)
Table Ethris RNA Vaccines Main Business and Markets Served
Table Tiba Biotechnology RNA Vaccines Production Sites and Area Served
Table Tiba Biotechnology RNA Vaccines Product Introduction, Application and Specification
Table Tiba Biotechnology RNA Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Tiba Biotechnology RNA Vaccines Production Growth Rate (2014-2019)
Table Tiba Biotechnology RNA Vaccines Production Market Share (2014-2019)
Figure Tiba Biotechnology RNA Vaccines Revenue Market Share (2014-2019)
Table Tiba Biotechnology RNA Vaccines Main Business and Markets Served
Figure Global RNA Vaccines Production (K Doses) Growth Rate Forecast 2019-2025
Figure Global RNA Vaccines Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global RNA Vaccines Sales Price (USD/Dose) Forecast 2019-2025
Figure North America RNA Vaccines Production Growth Rate Forecast 2019-2025 (K Doses)
Figure North America RNA Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe RNA Vaccines Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Europe RNA Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China RNA Vaccines Production Growth Rate Forecast 2019-2025 (K Doses)
Figure China RNA Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan RNA Vaccines Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Japan RNA Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia RNA Vaccines Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Southeast Asia RNA Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India RNA Vaccines Production Growth Rate Forecast 2019-2025 (K Doses)
Figure India RNA Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Doses) of RNA Vaccines by Type (2019-2025)
Table Global Consumption (K Doses) of RNA Vaccines by Application (2019-2025)
Table RNA Vaccines Distributors List
Table RNA Vaccines Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
mRNAワクチン及び治療薬の世界市場：市場規模・現状・予測 mRNA vaccine is the drugs prepared using advanced technologies using mRNA as the genetic material. mRNA vaccines are a more efficient alternative owing to their enhanced immunogenicity, higher potency, rapid development, relatively cheaper and safer over conventional vaccines.In 2018, the global mRN…- がんワクチン薬パイプラインの世界市場：市場規模・現状・予測 Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity.Germany, the U.S. and Japan represent the largest markets for cancer vaccine manufacturers. In 2018, the global Cancer Vaccines Drug Pipeline market size was xx mil…
- 世界のDNAワクチン市場：専門的調査 The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.No…
- 世界の腸チフスワクチン市場：専門的調査 Typhoid fever is contracted by drinking or eating the Salmonella bacteria in contaminated food or water. Typhoid Fever Vaccines prevent typhoid fever and provide protection against it. The global Typhoid Fever Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the …
- ヒト狂犬病ワクチンの世界市場：インサイト・予測 Rabies vaccine is a vaccine used to prevent rabies.They can be used to prevent rabies before and for a period of time after exposure to the virus such as by a dog or bat bite.The immunity that develops is long lasting after a full course.Global human rabies vaccines market is expected to witness rob…